Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver ...
Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
First patients dosed in Phase 3 SYNCHRONY Outcomes study of lead candidate efruxifermin (EFX) in patients with compensated ...
Enerflex (TSE:EFX) Reaches New 12-Month High After Analyst Upgrade
Enerflex Ltd. (TSE:EFX – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Acumen Capital raised their price target on the stock from C$12.00 to C$15.00. The ...
Reporter-Herald13h
Winter Wonderlights returning to East Loveland Saturday with new additions
The display will light up at 5 p.m. and run until 9 p.m. nightly on the east side of Chapungu Sculpture Park, 5995 Sky Pond ...
Equifax (EFX) Receives a Buy from J.P. Morgan
In a report released today, Andrew Steinerman from J.P. Morgan maintained a Buy rating on Equifax (EFX – Research Report), with a price target ...
Equifax price target lowered to $283 from $304 at JPMorgan
JPMorgan analyst Andrew Steinerman lowered the firm’s price target on Equifax (EFX) to $283 from $304 and keeps an Overweight rating on the ...